Summary by Futu AI
EC Healthcare announced its performance for the fiscal year ending March 31, 2024, with total revenue of HKD 421.1 million, a year-on-year increase of 8.7%. Medical service revenue was HKD 263.19 million, aesthetic medical, beauty and wellness service revenue was HKD 130.94 million, and veterinary and other service revenue was HKD 26.97 million. However, profit before interest, tax, depreciation, and amortization decreased by 9.8%, and net profit fell sharply by 85.3% to HKD 15.7 million. Basic and diluted loss per share was 1.6 HK cents. The company did not declare a final dividend during the period. As of the end of the reporting period, the company had HKD 593.1 million in cash and cash equivalents, and total debt was HKD 920.7 million. The debt-to-equity ratio was 38.3%. The company conducted...Show More